FDA Information
On May 10th 2006, the United States Food and Drug Administration (FDA) approved safety labeling revisions for amoxicillin capsules, tablets, chewable tablets, and powder for oral suspension (Amoxil®, made by GlaxoSmithKline) to advise of an increased risk for toxicity associated with use of amoxicillin in elderly patients and others with impaired renal function.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What storage conditions are needed for this medicine?
In case of an emergency/overdose